Defining Retinal Structures Using Hyperspectral Retinal Imaging
NCT: NCT07555574 · RECRUITING
Brief Summary
This study evaluates hyperspectral retinal imaging as a novel, non-invasive imaging technique to characterise retinal and optic nerve structures in healthy individuals and patients with eye disease. Hyperspectral imaging captures retinal data across multiple wavelengths to generate detailed spectral information that may reveal features not visible with conventional retinal photography. Approximately 1000 participants will undergo multi-modal ophthalmic imaging in Melbourne, Australia, including hyperspectral imaging, OCT, fundus photography, and related tests. The study aims to compare hyperspectral imaging with standard imaging methods and assess its ability to identify retinal biomarkers associated with diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration.
Frequently Asked Questions
What is Defining Retinal Structures Using Hyperspectral Retinal Imaging?
Defining Retinal Structures Using Hyperspectral Retinal Imaging is a clinical trial registered under NCT07555574. Current status: RECRUITING.
What is the status of NCT07555574?
The current status of NCT07555574 (Defining Retinal Structures Using Hyperspectral Retinal Imaging) is: RECRUITING.
When did Defining Retinal Structures Using Hyperspectral Retinal Imaging start?
Defining Retinal Structures Using Hyperspectral Retinal Imaging started on 2025-01-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.